Immunosenenescence: Role of cytomegalovirus

Experimental Gerontology

Volumn 54, Issue , 2014, Pages 1-5

  Pawelec, Graham ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

CMV; Immune risk profile; Immunosenescence; Mortality; Vacination

Indexed keywords

ADAPTIVE IMMUNITY; AGED; CD8+ T LYMPHOCYTE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE ERADICATION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; AGED; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE ERADICATION; HUMANS; IMMUNITY, INNATE; T-LYMPHOCYTES;

EID: 84898803220     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2013.11.010     Document Type: Review

References (75)

1. Almanzar G., Schwaiger S., Jenewein B., Keller M., Grubeck-Loebenstein B., Wurzner R., Schonitzer D. IFN-gamma production by CMV-specific CD8+ T cells is high in elderly donors. Exp. Gerontol. 2004, 39(5):863-865. (author reply 867-8.).
2. Almanzar G., Schwaiger S., Jenewein B., Keller M., Herndler-Brandstetter D., Wurzner R., Schonitzer D., Grubeck-Loebenstein B. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J. Virol. 2005, 79(6):3675-3683.
3. Appay V., Dunbar P.R., Callan M., Klenerman P., Gillespie G.M., Papagno L., Ogg G.S., King A., Lechner F., Spina C.A., Little S., Havlir D.V., Richman D.D., Gruener N., Pape G., Waters A., Easterbrook P., Salio M., Cerundolo V., McMichael A.J., Rowland-Jones S.L. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 2002, 8(4):379-385.
4. Barton E.S., White D.W., Cathelyn J.S., Brett-McClellan K.A., Engle M., Diamond M.S., Miller V.L., Virgin H.W. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 2007, 447(7142):326-329.
5. Bruunsgaard H., Pedersen B.K. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 2003, 23(1):15-39.
6. Chen W.H., Kozlovsky B.F., Effros R.B., Grubeck-Loebenstein B., Edelman R., Sztein M.B. Vaccination in the elderly: an immunological perspective. Trends Immunol. 2009, 30(7):351-359.
7. Chidrawar S., Khan N., Wei W., McLarnon A., Smith N., Nayak L., Moss P. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin. Exp. Immunol. 2009, 155(3):423-432.
8. Cohen H.J., Harris T., Pieper C.F. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am. J. Med. 2003, 114(3):180-187.
9. Couzi L., Levaillant Y., Jamai A., Pitard V., Lassalle R., Martin K., Garrigue I., Hawchar O., Siberchicot F., Moore N., Moreau J.F., Dechanet-Merville J., Merville P. Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation. J. Am. Soc. Nephrol. 2010, 21(1):181-188.
10. Dechanet J., Merville P., Lim A., Retiere C., Pitard V., Lafarge X., Michelson S., Meric C., Hallet M.M., Kourilsky P., Potaux L., Bonneville M., Moreau J.F. Implication of gammadelta T cells in the human immune response to cytomegalovirus. J. Clin. Invest. 1999, 103(10):1437-1449.
11. Derhovanessian E., Maier A.B., Beck R., Jahn G., Hähnel K., Slagboom P.E., De Craen A.J.M., Westendorp R.G.J., Pawelec G. Hallmark features of immunosenescence are absent in familial longevity. J. Immunol. 2010, 185(8):4618-4624.
12. Derhovanessian E., Maier A.B., Hähnel K., Beck R., de Craen A.J., Slagboom E.P., Westendorp R.G., Pawelec G. Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late differentiated CD4+ and CD8+ T-cells in humans. J. Gen. Virol. 2011, 92(12):2746-2756.
13. Derhovanessian E., Maier A.B., Hähnel K., Zelba H., de Craen A.J., Roelofs H., Slagboom E.P., Westendorp R.G., Pawelec G. Lower proportion of naïve peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly people. Age (Dordr). 2013, 35(4):1387-1399.
14. Derhovanessian E., Theeten H., Hähnel K., Van Damme P., Cools N., Pawelec G. Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine 2013, 31(4):685-690.
15. Dowd J.B., Aiello A.E., Alley D.E. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol. Infect. 2009, 137(1):58-65.
16. Effros R.B., Dagarag M., Spaulding C., Man J. The role of CD8+ T-cell replicative senescence in human aging. Immunol. Rev. 2005, 205:147-157.
17. Ferguson F.G., Wikby A., Maxson P., Olsson J., Johansson B. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J. Gerontol. A Biol. Sci. Med. Sci. 1995, 50(6):B378-B382.
18. Franceschi C., Bonafe M., Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000, 18(16):1717-1720.
19. Goronzy J.J., Fulbright J.W., Crowson C.S., Poland G.A., O'Fallon W.M., Weyand C.M. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J. Virol. 2001, 75(24):12182-12187.
20. Gravenstein S., Drinka P., Duthie E.H., Miller B.A., Brown C.S., Hensley M., Circo R., Langer E., Ershler W.B. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak. J. Am. Geriatr. Soc. 1994, 42(3):245-251.
21. Griffiths S.J., Riddell N.E., Masters J., Libri V., Henson S.M., Wertheimer A., Wallace D., Sims S., Rivino L., Larbi A., Kemeny D.M., Nikolich-Zugich J., Kern F., Klenerman P., Emery V.C., Akbar A.N. Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA. J. Immunol. 2013, 190(11):5363-5372.
22. Grubeck-Loebenstein B., Della Bella S., Iorio A.M., Michel J.P., Pawelec G., Solana R. Immunosenescence and vaccine failure in the elderly. Aging Clin. Exp. Res. 2009, 21(3):201-209.
23. Gruver A.L., Hudson L.L., Sempowski G.D. Immunosenescence of ageing. J. Pathol. 2007, 211(2):144-156.
24. Hadrup S.R., Strindhall J., Kollgaard T., Seremet T., Johansson B., Pawelec G., thor Straten P., Wikby A. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 2006, 176(4):2645-2653.
25. Hansen S.G., Powers C.J., Richards R., Ventura A.B., Ford J.C., Siess D., Axthelm M.K., Nelson J.A., Jarvis M.A., Picker L.J., Fruh K. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 2010, 328(5974):102-106.
26. Horiuchi S., Wilmoth J.R. Age patterns of the life table aging rate for major causes of death in Japan, 1951-1990. J. Gerontol. A Biol. Sci. Med. Sci. 1997, 52(1):B67-B77.
27. Huppert F.A., Pinto E.M., Morgan K., Brayne C. Survival in a population sample is predicted by proportions of lymphocyte subsets. Mech. Ageing Dev. 2003, 124(4):449-451.
28. Jones R. Trends in unscheduled care. Brit. J. Healthcare Management 2013, 19(6):301-304.
29. Kern F., Khatamzas E., Surel I., Frommel C., Reinke P., Waldrop S.L., Picker L.J., Volk H.D. Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms. Eur. J. Immunol. 1999, 29(9):2908-2915.
30. Khan N., Shariff N., Cobbold M., Bruton R., Ainsworth J.A., Sinclair A.J., Nayak L., Moss P.A. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol. 2002, 169(4):1984-1992.
31. Kuningas M., May L., Tamm R., van Bodegom D., van den Biggelaar A.H., Meij J.J., Frolich M., Ziem J.B., Suchiman H.E., Metspalu A., Slagboom P.E., Westendorp R.G. Selection for genetic variation inducing pro-inflammatory responses under adverse environmental conditions in a Ghanaian population. PLoS ONE 2009, 4(11):e7795.
32. Lelic A., Verschoor C.P., Ventresca M., Parsons R., Evelegh C., Bowdish D., Betts M.R., Loeb M.B., Bramson J.L. The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by age. PLoS Pathog. 2012, 8(12):e1003076. (Epub 2012 Dec 13.). 10.1371/journal.ppat.1003076.
33. Letsch A., Knoedler M., Na I.K., Kern F., Asemissen A.M., Keilholz U., Loesch M., Thiel E., Volk H.D., Scheibenbogen C. CMV-specific central memory T cells reside in bone marrow. Eur. J. Immunol. 2007, 37(11):3063-3068.
34. Looney R.J., Falsey A., Campbell D., Torres A., Kolassa J., Brower C., McCann R., Menegus M., McCormick K., Frampton M., Hall W., Abraham G.N. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin. Immunol. 1999, 90(2):213-219.
35. McElhaney J.E., Zhou X., Talbot H.K., Soethout E., Bleackley R.C., Granville D.J., Pawelec G. The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 2012, 30(12):2060-2067.
36. Merino J., Martinez-Gonzalez M.A., Rubio M., Inoges S., Sanchez-Ibarrola A., Subira M.L. Progressive decrease of CD8high+CD28+ CD57-cells with ageing. Clin. Exp. Immunol. 1998, 112(1):48-51.
37. Murasko D.M., Weiner P., Kaye D. Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin. Exp. Immunol. 1987, 70(2):440-448.
38. Nickel P., Bold G., Presber F., Biti D., Babel N., Kreutzer S., Pratschke J., Schonemann C., Kern F., Volk H.D., Reinke P. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. Transpl. Immunol. 2009, 20(4):238-242.
39. Nilsson B.O., Ernerudh J., Johansson B., Evrin P.E., Lofgren S., Ferguson F.G., Wikby A. Morbidity does not influence the T-cell immune risk phenotype in the elderly: findings in the Swedish NONA Immune Study using sample selection protocols. Mech. Ageing Dev. 2003, 124(4):469-476.
40. Northfield J., Lucas M., Jones H., Young N.T., Klenerman P. Does memory improve with age? CD85j (ILT-2/LIR-1) expression on CD8 T cells correlates with 'memory inflation' in human cytomegalovirus infection. Immunol. Cell Biol. 2005, 83(2):182-188.
41. Ogata K., An E., Shioi Y., Nakamura K., Luo S., Yokose N., Minami S., Dan K. Association between natural killer cell activity and infection in immunologically normal elderly people. Clin. Exp. Immunol. 2001, 124(3):392-397.
42. Olsson J., Wikby A., Johansson B., Lofgren S., Nilsson B.O., Ferguson F.G. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech. Ageing Dev. 2000, 121(1-3):187-201.
43. Ouyang Q., Wagner W.M., Voehringer D., Wikby A., Klatt T., Walter S., Muller C.A., Pircher H., Pawelec G. Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp. Gerontol. 2003, 38(8):911-920.
44. Ouyang Q., Wagner W.M., Walter S., Muller C.A., Wikby A., Aubert G., Klatt T., Stevanovic S., Dodi T., Pawelec G. An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech. Ageing Dev. 2003, 124(4):477-485.
45. Ouyang Q., Wagner W.M., Wikby A., Walter S., Aubert G., Dodi A.I., Travers P., Pawelec G. Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J. Clin. Immunol. 2003, 23(4):247-257.
46. Pass R.F., Zhang C., Evans A., Simpson T., Andrews W., Huang M.L., Corey L., Hill J., Davis E., Flanigan C., Cloud G. Vaccine prevention of maternal cytomegalovirus infection. N. Engl. J. Med. 2009, 360(12):1191-1199.
47. Pawelec G., Ferguson F.G., Wikby A. The SENIEUR protocol after 16years. Mech. Ageing Dev. 2001, 122(2):132-134.
48. Pawelec G., Derhovanessian E., Larbi A., Strindhall J., Wikby A. Cytomegalovirus and human immunosenescence. Rev. Med. Virol. 2009, 19(1):47-56.
49. Peres A., Bauer M., da Cruz I.B., Nardi N.B., Chies J.A. Immunophenotyping and T-cell proliferative capacity in a healthy aged population. Biogerontology 2003, 4(5):289-296.
50. Roberts-Thomson I.C., Whittingham S., Youngchaiyud U., Mackay I.R. Ageing, immune response, and mortality. Lancet 1974, 2(7877):368-370.
51. Saurwein-Teissl M., Lung T.L., Marx F., Gschosser C., Asch E., Blasko I., Parson W., Bock G., Schonitzer D., Trannoy E., Grubeck-Loebenstein B. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J. Immunol. 2002, 168(11):5893-5899.
52. Schwanninger A., Weinberger B., Weiskopf D., Herndler-Brandstetter D., Reitinger S., Gassner C., Schennach H., Parson W., Wurzner R., Grubeck-Loebenstein B. Age-related appearance of a CMV-specific high-avidity CD8+ T cell clonotype which does not occur in young adults. Immun. Ageing 2008, 5:14.
53. Simanek A.M., Dowd J.B., Pawelec G., Melzer D., Dutta A., Aiello A.E. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 2011, 6(2):e16103. (17).
54. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect. Dis. 2007, 7(10):658-666.
55. Stowe R.P., Kozlova E.V., Yetman D.L., Walling D.M., Goodwin J.S., Glaser R. Chronic herpesvirus reactivation occurs in aging. Exp. Gerontol. 2007, 42(6):563-570.
56. Strandberg T.E., Pitkala K.H., Tilvis R.S. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease. JAMA 2009, 301(4):380-382.
57. Strindhall J., Nilsson B.O., Lofgren S., Ernerudh J., Pawelec G., Johansson B., Wikby A. No Immune Risk Profile among individuals who reach 100years of age: findings from the Swedish NONA immune longitudinal study. Exp. Gerontol. 2007, 42(8):753-761.
58. Sylwester A.W., Mitchell B.L., Edgar J.B., Taormina C., Pelte C., Ruchti F., Sleath P.R., Grabstein K.H., Hosken N.A., Kern F., Nelson J.A., Picker L.J. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 2005, 202(5):673-685.
59. Tarazona R., DelaRosa O., Alonso C., Ostos B., Espejo J., Pena J., Solana R. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech. Ageing Dev. 2000, 121(1-3):77-88.
60. Trzonkowski P., Debska-Slizien A., Jankowska M., Wardowska A., Carvalho-Gaspar M., Hak L., Moszkowska G., Bzoma B., Mills N., Wood K.J., Mysliwska J., Rutkowski B. Immunosenescence increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T-cells. Mech. Ageing Dev. 2010, 131(2):96-104.
61. Trzonkowski P., Mysliwska J., Godlewska B., Szmit E., Lukaszuk K., Wieckiewicz J., Brydak L., Machala M., Landowski J., Mysliwski A. Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients. Brain Behav. Immun. 2004, 18(2):135-148.
62. Trzonkowski P., Mysliwska J., Pawelec G., Mysliwski A. From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderly. Biogerontology 2009, 10(1):83-94.
63. Trzonkowski P., Mysliwska J., Szmit E., Wieckiewicz J., Lukaszuk K., Brydak L.B., Machala M., Mysliwski A. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination-an impact of immunosenescence. Vaccine 2003, 21(25-26):3826-3836.
64. Turner J.E., Campbell J.P., Edwards K.M., Howarth L.J., Pawelec G., Aldred S., Moss P., Drayson M.T., Burns V.E., Bosch J.A. Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults. Age (Dordr). 2013, (Jul 12. [Epub ahead of print]).
65. Vallejo A.N. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol. Rev. 2005, 205:158-169.
66. Vescovini R., Telera A., Fagnoni F.F., Biasini C., Medici M.C., Valcavi P., di Pede P., Lucchini G., Zanlari L., Passeri G., Zanni F., Chezzi C., Franceschi C., Sansoni P. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells. Exp. Gerontol. 2004, 39(8):1233-1243.
67. Vezys V., Yates A., Casey K.A., Lanier G., Ahmed R., Antia R., Masopust D. Memory CD8 T-cell compartment grows in size with immunological experience. Nature 2009, 457(7226):196-199.
68. Wallace D.L., Zhang Y., Ghattas H., Worth A., Irvine A., Bennett A.R., Griffin G.E., Beverley P.C., Tough D.F., Macallan D.C. Direct measurement of T cell subset kinetics in vivo in elderly men and women. J. Immunol. 2004, 173(3):1787-1794.
69. Wang G.C., Kao W.H., Murakami P., Xue Q.L., Chiou R.B., Detrick B., McDyer J.F., Semba R.D., Casolaro V., Walston J.D., Fried L.P. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am. J. Epidemiol. 2010, 171(10):1144-1152.
70. Waterstrat A., Van Zant G. Effects of aging on hematopoietic stem and progenitor cells. Curr. Opin. Immunol. 2009, 21(4):408-413.
71. Wayne S.J., Rhyne R.L., Garry P.J., Goodwin J.S. Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. J. Gerontol. 1990, 45(2):M45-M48.
72. White D.W., Suzanne Beard R., Barton E.S. Immune modulation during latent herpesvirus infection. Immunol. Rev. 2012, 245(1):189-208.
73. Wikby A., Johansson B., Ferguson F., Olsson J. Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp. Gerontol. 1994, 29(5):531-541.
74. Wikby A., Maxson P., Olsson J., Johansson B., Ferguson F.G. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech. Ageing Dev. 1998, 102(2-3):187-198.
75. Wistuba-Hamprecht K., Frasca D., Blomberg B., Pawelec G., Derhovanessian E. Age-associated alterations in γδ T-cells are present predominantly in individuals infected with Cytomegalovirus. Immun. Ageing 2013, 10(1):26.